Ping Zhang

Ping Zhang is recorded as Board Member at Gyre Therapeutics, Inc. (GYRE) since January 5, 2025 and CEO at Gyre Therapeutics, Inc. (GYRE). The newest filing on record that lists Ping Zhang as CEO at Gyre Therapeutics, Inc. (GYRE) is dated April 27, 2026. Gyre Therapeutics, Inc. reported in an 8-K filed August 11, 2025 that Ping Zhang was appointed Interim Chief Executive Officer, effective August 5, 2025. Gyre Therapeutics, Inc. reported in an 8-K filed January 6, 2025 that Ping Zhang was appointed Class I director, effective January 5, 2025. The proxy statement of Gyre Therapeutics, Inc. reports total compensation of $4,096,623 for Ping Zhang in fiscal 2025, including a base salary of $189,777. Gyre Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Gyre Therapeutics, Inc. includes Charles Wu (CEO and Board Member), Dr. Han Ying (CEO), Dr. Ying Luo (CEO and Board Member) and 7 others.